BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sergi CM. NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection. Vaccines (Basel) 2022;10:1307. [PMID: 36016195 DOI: 10.3390/vaccines10081307] [Reference Citation Analysis]
2 Abd HA, Kasim AA, Shareef LG. Serum levels of α1-antitrypsin, interleukin-1β and interleukin-6 in Iraqi COVID-19 patients: A cross-sectional study. F1000Res 2022;11:921. [DOI: 10.12688/f1000research.124473.1] [Reference Citation Analysis]
3 Yong Y, Zhang L, Hu Y, Wu J, Yan L, Pan Y, Tang Y, Yu L, Law BY, Yu C, Zhou J, Li M, Qin D, Zhou X, Wu A. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109093] [Reference Citation Analysis]
4 García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470. [PMID: 35663992 DOI: 10.3389/fimmu.2022.894470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chemarin M, Dufies O, Mazet A, Mellan E, Coudereau R, Py BF, Boyer L, Venet F. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection]. Med Sci (Paris) 2022;38:545-52. [PMID: 35766852 DOI: 10.1051/medsci/2022080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Palacios Y, Chavez-galan L. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? Pharmaceuticals 2022;15:616. [DOI: 10.3390/ph15050616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]